Implantable Continuous Glucose Monitoring System

On june 21 2018 the fda announced the approval of the implantable eversense cgm device.

Implantable continuous glucose monitoring system.

Designed to help diabetes patients keep track of their blood glucose levels with ease. Senseonics eversense continuous glucose monitoring system is the first implantable continuous glucose monitor approved for type 1 and type 2 diabetics. Percent of patients with targeted time in range and time in hypoglycemia with the eversense cgm system. Read about risks and benefits here.

Eversense provides continuous blood glucose monitoring for up to 90 days via an under the skin sensor a removable and rechargeable smart transmitter and a convenient app for real time diabetes monitoring and management. The system is indicated for use to replace fingerstick blood glucose bg measurements for diabetes treatment decisions. The eversense continuous glucose monitoring cgm system is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. Fda approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes for immediate release.

Dexcom continuous glucose monitoring discover smart and simple continuous glucose monitoring. The eversense continuous glucose monitoring system is a prescription device that provides real time glucose monitoring every five minutes for up to 90 days at a time for people with diabetes. Longitudinal analysis of real world performance of an implantable continuous glucose sensor over multiple sensor insertion and removal cycles publication 2020 attd. The eversense continuous glucose monitoring cgm system feels like something out of the future.

The eclipse icgm system is currently under development and is not yet approved cleared or otherwise available for commercial or public distribution. You have a tiny sensor under the skin in your arm that broadcasts your glucose levels in real time. Initial human implant trials have been completed and preparations for additional human trials are underway. The system is currently undergoing clinical evaluation.

You get an accurate reading without the hassle of inserting sensors. With the eversense 90 day cgm system you can actively manage your diabetes simply and with confidence.